

Histogenics is a tissue regeneration company developing breakthrough treatments for long-lasting joint repair. Among its major competitors, Histogenics is ranked in 8th place for NPS while Genomatica is 1st, and Zimmer Biomet is 2nd.Their current market cap is $15.33M